FibroGen
FGEN
FGEN
144 hedge funds and large institutions have $767M invested in FibroGen in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 43 reducing their positions, and 11 closing their positions.
Holders
144
Holders Change
+4
Holders Change %
+2.86%
% of All Funds
3.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
21
Increased
51
Reduced
43
Closed
11
Calls
$4.08M
Puts
$8.42M
Net Calls
-$4.34M
Net Calls Change
-$4.76M
Top Buyers
Top Sellers
| 1 |
PC
1
PointState Capital
New York
|
$0 |
| 2 |
EC
2
EcoR1 Capital
San Francisco,
California
|
$1.04M |
| 3 |
3
Millennium Management
New York
|
$3.53M |
| 4 |
4
Morgan Stanley
New York
|
$4.05M |
| 5 |
NC
5
Nexthera Capital
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Walleye Trading
New York
| – | -$385K | -720 | Closed |
|
|
BCM
152
Bayesian Capital Management
Brooklyn,
New York
| – | -$321K | -600 | Closed |
|
153
HSBC Holdings
London,
United Kingdom
| – | -$236K | -441 | Closed |
|
|
TRCT
154
Tower Research Capital (TRC)
New York
| – | -$56K | -105 | Closed |
|